Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890
Tclin 2 | 602

IMPC Term

decreased leukocyte cell numbe... 1 | 54

Disease

Cancer 6 | 2,346
diabetes mellitus 5 | 1,663
ovarian cancer 5 | 8,484
Alzheimer's disease 4 | 644
Breast cancer 4 | 3,094
Carcinoma 4 | 2,147
Mammary Neoplasms 4 | 410
Obesity 4 | 616
interstitial cystitis 4 | 2,299
lung cancer 4 | 4,466
non-small cell lung cancer 4 | 2,798
osteosarcoma 4 | 7,933
psoriasis 4 | 6,685
Liver carcinoma 3 | 217
Parkinson's disease 3 | 364
Prostatic Neoplasms 3 | 471
Schizophrenia 3 | 501
atypical teratoid / rhabdoid tumor 3 | 4,369
glioblastoma 3 | 5,572
pituitary cancer 3 | 1,972
Adenocarcinoma 2 | 115
Adenoma 2 | 165
Arthritis 2 | 248
Asthma 2 | 349
Autistic Disorder 2 | 320
Colorectal Neoplasms 2 | 217
Diarrhea 2 | 155
Disease Progression 2 | 125
Epilepsy 2 | 346
Gout 2 | 93
Hyperactive behavior 2 | 31
Hyperglycemia 2 | 120
Hyperinsulinism 2 | 63
Inflammatory bowel disease 2 | 142
Juvenile arthritis 2 | 124
Kidney disease 2 | 396
Lung Neoplasms 2 | 171
Neoplasm Invasiveness 2 | 127
Neoplasm Metastasis 2 | 138
Neoplastic Cell Transformation 2 | 81
Pain agnosia 2 | 99
Peripheral Neuropathy 2 | 303
Pick disease 2 | 1,893
Skin Neoplasms 2 | 49
Squamous cell carcinoma 2 | 94
Vascular disease 2 | 281
adrenocortical carcinoma 2 | 1,427
cutaneous lupus erythematosus 2 | 1,056
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
hepatocellular carcinoma 2 | 532
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
medulloblastoma 2 | 1,524
medulloblastoma, large-cell 2 | 6,234
oligodendroglioma 2 | 2,849
ovarian neoplasm 2 | 97
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
pilocytic astrocytoma 2 | 3,086
posterior fossa group B ependymoma 2 | 1,530
primitive neuroectodermal tumor 2 | 3,031
sarcoidosis 2 | 358
spina bifida 2 | 1,064
subependymal giant cell astrocytoma 2 | 2,287
Anxiety Disorders 1 | 37
Arthritis, Experimental 1 | 39
Bradycardia 1 | 24
Carcinoma of thyroid 1 | 17
Cardiomegaly 1 | 66
Catalepsy 1 | 15
Chloracne 1 | 32
Colon Carcinoma 1 | 25
Complex regional pain syndrome 1 | 12
DOID:2627 1 | 14
Dumping syndrome 1 | 9
Epicondylitis 1 | 19
Fatty liver disease 1 | 84
Fibromyalgia 1 | 22
Fibrosis 1 | 40
Glioma 1 | 65
Growth Disorders 1 | 33
Head and Neck Neoplasms 1 | 23
Irritable bowel syndrome 1 | 59
Kidney cancer 1 | 118
Lupus erythematosus 1 | 80
Malignant glioma 1 | 23
Meningioma 1 | 26
Muscle Rigidity 1 | 5
Oropouche fever 1 | 2
Papilloma 1 | 27
Paronychia 1 | 7
Precancerous Conditions 1 | 69
Pulmonary Fibrosis 1 | 66
Rhinitis 1 | 46
Silver-Russell syndrome 1 | 37
Skin disease 1 | 65
Squamous cell carcinoma of the head and neck 1 | 24
Tularemia 1 | 22
chronic kidney disease 1 | 90

Tissue

Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Nervous System 8 | 18,561
Blood and immune system 7 | 17,995
Cardiovascular System 7 | 17,958
Digestive Tract 7 | 18,473
Liver and Pancreas 7 | 18,136
Male tissues 7 | 17,969
Respiratory system 7 | 17,484
Skin and soft tissues 7 | 18,115
Urinary Tract 7 | 18,444

Target Family

Non-IDG 5 | 11,971
Kinase 3 | 634

Grant Application

5R01DK060729-09 8 | 8
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Neurotensin/neuromedin N NTS Tbio Non-IDG -3.53340 3485.1 161
Pro-epidermal growth factor EGF Tbio Non-IDG -3.74376 4837.7 851
Epidermal growth factor receptor EGFR Tclin Kinase -3.95948 9318.1 4989
Insulin-like growth factor 1 receptor IGF1R Tclin Kinase -3.32234 2286.3 1275
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Tuftelin-interacting protein 11 TFIP11 Tbio Non-IDG -1.72578 62.9 73
RAC-alpha serine/threonine-protein kinase AKT1 Tchem Kinase -4.29533 18275.3 3137